• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of and finding treatments for complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia (FM), long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Preparation for federal US CFSAC May meeting

Hope123

Senior Member
Messages
1,266
Federal US CFSAC meeting just announced - MAY 10!

As many of you know, the US federal CFS advisory committe meeting takes place twice a year - usually in May and either October or November. The next meeting has not been scheduled yet [NOW SCHEDULED FOR MAY 10] but I thought I'd start a thread to get people thinking about it, specifically what questions/ issues we have that have not been addressed well and also which gov't departments or officials we want to hear from.

Also, it might be interesting to ask before the meeting whether international advocates can be counted in this time as the last meeting did not allow participation internationally although many around the world depend on US CFS research also. Note that CFSAC is now broadcasted live (and archived) online and people can write to or sign up to speak in-person or on the phone during the CFSAC meeting.

If we get some good ideas beforehand, it might be worth it to send it to Dr. Wanda Jones, who helps run the meeting, or members of the CFSAC committee.

Here is the CFSAC site for more info.

http://www.hhs.gov/advcomcfs/
 

Otis

Señor Mumbler
Messages
1,117
Location
USA
Funny you should say that

As many of you know, the US federal CFS advisory committe meeting takes place twice a year - usually in May and either October or November. The next meeting has not been scheduled yet but I thought I'd start a thread to get people thinking about it, specifically what questions/ issues we have that have not been addressed well and also which gov't departments or officials we want to hear from.

Also, it might be interesting to ask before the meeting whether international advocates can be counted in this time as the last meeting did not allow participation internationally although many around the world depend on US CFS research also. Note that CFSAC is now broadcasted live (and archived) online and people can write to or sign up to speak in-person or on the phone during the CFSAC meeting.

If we get some good ideas beforehand, it might be worth it to send it to Dr. Wanda Jones, who helps run the meeting, or members of the CFSAC committee.

Here is the CFSAC site for more info.

http://www.hhs.gov/advcomcfs/

I just posted the following on another thread "I think we need to find a way to spin up Wanda Jones - I would not want to get in her way if she were on a mission."

Otis
 

leelaplay

member
Messages
1,576
Islandfin posted that there's a new CDC head overall -- Dr. Frieden. One idea would be to invite him to the meeting. After all, CDC CFS head is "acting" right now and we don't have an official head after Reeves left.

http://www.nytimes.com/2010/03/16/health/16prof.html?scp=2&sq=Thomas Frieden&st=cse

I think that's a great idea Hope. And do like that you're planning ahead. You're helping combat my internal malaise. I sort of feel, and I may be reflective of many out there, that we did a big push for October - what more is there to do.

But of course there is lots to do. We need to get everyone going again. As well as inviting Dr Frieden, should we invite Dr Unger and ask for her position, and what she has done/is doing to help get the the CFSAC recommendations implemented?

Another idea - in Oct Wanda Jones said she had a list of all past recommendations and what actions have been taken to date. It would be great to have access to that document to help with planning.

Here are the recommendations from Oct:

Committee RecommendationsOctober 29-30, 2009

CFSAC voted upon and agreed for the following recommendations to be
forwarded to the Assistant Secretary and the Secretary for Health :

The specific recommendations articulated by the Committee are:

1.

Establish Regional Centers funded by DHHS for clinical care, research,
and education on CFS. (Resubmitted from May 2009)
2.

AHRQ is expected to complete a review of CFS for the NIH State of the
Knowledge Workshop. After this process, we recommend that the findings be
communicated immediately to key medical education, accreditation, licensing,
specialty, and certification boards and organizations. In addition, we
recommend a Surgeon General’s letter be disseminated to inform clinicians
and other health professionals throughout the US and its territories on the
impact of CFS on the health of US adults and children.
3.

Establish progressive leadership at the CDC that can achieve efficient,
meaningful progress in CFS research, clinical care, and education.
(Resubmitted from May 2009)
4.

Multiple case definitions currently are used for CFS. The CFSAC rejects
the empirical case definition and the terminology of “chronic un-wellness”,
both of which are endorsed by the CDC, and recommends that DHHS recognize a
need for and commit to support a national effort to arrive at a consensus
definition of CFS that is accurate, standardized, and reflective of the true
disease.
5.

Provide adequate funding to CDC to effectively carry out a detailed
5-year plan. This should include, but not be limited to, immediate progress
in these priority areas (Resubmitted from May 2009 with minor modification
to [a]):
1.

Identification of biomarkers, with increasing efforts in viral
etiology of CFS:
2.

Creation of updated guidelines for adult and pediatric CFS management
in full partnership with organizations representing CFS scientific and
clinical expertise;
3.

Provision of updated web-based guidelines for CFS management given our
current state of knowledge and expert opinion, again in full partnership
with organizations representing CFS clinical and scientific expertise; and
4.

Provision of comprehensive information about CFS in partnership with
CFS experts to the scientific community, medical and mental health
providers, educational institutions and the public for both adult and
pediatric CFS through DHHS resources.
 

Hope123

Senior Member
Messages
1,266
Islandfinn and Jspotila, yes, we should look at past recommendations and hold the gov't accountable for what they promised to do -- even if things aren't finished yet, we should get an accounting of what is in the works. I had e-mailed Dr. Jones after the last meeting to get a list of the recs that were carried out for CFSAC vs. non-CFS advisory committees (she said there was a comparison list) but didn't get a response from her. Supposedly the % of recs carried out were similar but I want to see it for myself and what types of actions were taken.
 

Stuart

Senior Member
Messages
154
I second your remarks Islandfinn! Dr. Frieden should be there and we should work with Wanda Jones on that.

I want an update on the federal blood study re: XMRV.

Jpsot, that is the billion ton elephant in room isn't it?

There are some answers that might be uncomfortable. If XMRV is in the blood supply, but the time and expense of mass testing prohibits a reliable and adequate supply of known safe blood, we are in a quandry. It seems likely that tissues would need to be tested before transplant as well, since the 2010 CROI found it was much more readily found in tissues than in the blood.

If XMRV has been in circulation for decades and if the rates of infection are growing, could be a nasty shock.

Public policy vs. politics vs. science will have it out (behind closed doors?), I feel a tiny bit better with Dr. Frieden around.

Fingers crossed!
 

justinreilly

Senior Member
Messages
2,498
Location
NYC (& RI)
Islandfinn and Jspotila, yes, we should look at past recommendations and hold the gov't accountable for what they promised to do -- even if things aren't finished yet, we should get an accounting of what is in the works. I had e-mailed Dr. Jones after the last meeting to get a list of the recs that were carried out for CFSAC vs. non-CFS advisory committees (she said there was a comparison list) but didn't get a response from her. Supposedly the % of recs carried out were similar but I want to see it for myself and what types of actions were taken.

Why the low % of recs carried out across other diseases?
Do they only form advisory committees for diseases they wish to ignore?

I would definately love to see Drs. Unger and Frieden. He sounds like he could help us since he seems to be very efficient/effective.

I'd like to get an update on a search for the permanent Chronic Viral Diseases head. FWIW I am demanding that it be an outside expert who has the expertise, will and ability to effect an appropriate treatment of ME quickly. An ostensibly well meaning insider is not acceptable to me given CDC's long sordid history regarding ME.
 

Hope123

Senior Member
Messages
1,266
I'm going to put a deadline on this thread to give it some closure. So, here's my thought - I will put whatever ideas people agree on by April 10 in a letter to Dr. Jones. Perhaps anyone who wants a copy can PM me and I will send them one so they can send it as well. I'll also try to get some back-up by sending it to the committee chair (Dr. Chris Snell?) as well. I'd welcome any help from Jspotila if she is able as she used to sit on CFSAC.

Here are some other thoughts I had:

- update from Social Security about what % of claims received are CFS-related; what % approved; how this compares with the general approval rate/ other illness approval rate; any variation among states (somehow, I've never heard numbers for this)

- update from child-related DHHS departments about protecting kids from being taken away from the parents due to CFS

- progress of arranging for the NIH state-of-the-art conference on CFS -- this has implication for establishing national guidelines for CFS care; I want the IACFS and other groups to have input into this esp. as IACFS is supposedly working on clinical guidelines for CFS
 

Hope123

Senior Member
Messages
1,266
Why the low % of recs carried out across other diseases?
Do they only form advisory committees for diseases they wish to ignore?

I would definately love to see Drs. Unger and Frieden. He sounds like he could help us since he seems to be very efficient/effective.

I'd like to get an update on a search for the permanent Chronic Viral Diseases head. FWIW I am demanding that it be an outside expert who has the expertise, will and ability to effect an appropriate treatment of ME quickly. An ostensibly well meaning insider is not acceptable to me given CDC's long sordid history regarding ME.

I have to look back at the notes but I think the % was like 20-30%. There's also only a few advisory committees for diseases - I think autism and HIV are two. It's actually a rare thing for a condition to have a federal advisory committee and we should take advantage of it as working with the a behemoth like the fed gov't is difficult.

My brother used to do advocacy work in DC and his take on it was that appointments based primarily on political points rather than actual expertise/ interest could be a huge obstacle to progress. That's what the NYT article made me think of.
 

jspotila

Senior Member
Messages
1,099
I'd welcome any help from Jspotila if she is able as she used to sit on CFSAC.

I am happy to help if I can, but want to clarify that I never sat on the CFSAC. I've offered public comment, that's all. To be honest, I don't think I have the patience to serve on that committee!
 

Hope123

Senior Member
Messages
1,266
I am happy to help if I can, but want to clarify that I never sat on the CFSAC. I've offered public comment, that's all. To be honest, I don't think I have the patience to serve on that committee!

My apologies. Brain wires crossed here. For some reason, I've seen your name in various places and got it crossed with Rebecca Artman (of PANDORA) who used to sit on the committee.
 

justinreilly

Senior Member
Messages
2,498
Location
NYC (& RI)
NYTimes article said Dr. Friedan is a fan of metrics and reporting so I'd like to ask him to make ME a reportable disease. This way med schools will be required to teach it.

I'd like to have a priority to the requests indicated in any communication to CDC as the number of things we (rightly) ask for can seem overwhelming. And of course, the old issues of funding and who heads the Chronic Viral Disease Branch should be the first two.
 

jspotila

Senior Member
Messages
1,099
FYI - The meeting has been scheduled for May 10th. Anyone wishing to give testimony must register in advance. Details are on the CFSAC's website.

Edited to add: Looks like the Federal Register notice has not yet been posted on the committee's website, so here is the text:
[Federal Register: April 1, 2010 (Volume 75, Number 62)]
[Notices]
[Page 16485]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr01ap10-74]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Chronic Fatigue Syndrome Advisory Committee

AGENCY: Department of Health and Human Services, Office of the
Secretary, Office of Public Health and Science.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S.
Department of Health and Human Services is hereby giving notice that
the Chronic Fatigue Syndrome Advisory Committee (CFSAC) will hold a
meeting. The meeting will be open to the public.

DATES: The meeting will be held on Monday, May 10, 2010. The meeting
will be held from 9 a.m. until 5 p.m.

ADDRESSES: Department of Health and Human Services; Room 800, Hubert H.
Humphrey Building; 200 Independence Avenue, SW., Washington, DC 20201.
For a map and directions to the Hubert H. Humphrey building, please
visit http://www.hhs.gov/about/hhhmap.html.

FOR FURTHER INFORMATION CONTACT: Wanda K. Jones, Dr.P.H.; Executive
Secretary, Chronic Fatigue Syndrome Advisory Committee, Department of
Health and Human Services; 200 Independence Avenue, SW., Hubert
Humphrey Building, Room 712E; Washington, DC 20201. Direct all CFSAC e-
mail inquiries to cfsac@hhs.gov.

SUPPLEMENTARY INFORMATION: CFSAC was established on September 5, 2002.
The Committee was established to advise, consult with, and make
recommendations to the Secretary, through the Assistant Secretary for
Health, on a broad range of topics including: (1) The current state of
the knowledge and research about the epidemiology and risk factors
relating to chronic fatigue syndrome, and identifying potential
opportunities in these areas; (2) current and proposed diagnosis and
treatment methods for chronic fatigue syndrome; and (3) development and
implementation of programs to inform the public, health care
professionals, and the biomedical, academic, and research communities
about advances in chronic fatigue syndrome.

The agenda for this meeting is being developed. The agenda will be
posted on the CFSAC Web site, http://www.hhs.gov/advcomcfs, when it is
finalized. The meeting will be broadcast over the Internet as a real-
time streaming video. It will also be recorded and archived on the
CFSAC Web site for viewers to watch at their convenience.

Public attendance at the meeting is limited to space available.
Individuals must provide a government-issued photo ID for entry into
the building where the meeting is scheduled to be held. Those attending
the meeting will need to sign in prior to entering the meeting room.
Individuals who plan to attend and need special assistance, such as
sign language interpretation or other reasonable accommodations, should
notify the designated contact person at cfsac@hhs.gov in advance.

The Committee is most interested in receiving public comment on the
CFSAC charter, which can be found at http://www.hhs.gov/advcomcfs/
charter/index.html. Members of the public will have the opportunity to
provide comment at the meeting if pre-registered. Individuals who wish
to address the Committee during the public comment session must pre-
register by April 26, 2010, via e-mail at cfsac@hhs.gov.

Time slots for public comment will be limited to three (3) minutes
per speaker; no exceptions will be made. Individuals registering should
submit a copy of their testimony in advance to cfsac@hhs.gov, prior to
the close of business on April 26, 2010.

Members of the public who wish to have printed material distributed
to CFSAC members for review should submit, at a minimum, one copy of
the material to the Executive Secretary at cfsac@hhs.gov, prior to
close of business (5 p.m. EDT) on Monday, April 26, 2010. Submissions
are limited to five typewritten pages.

If you wish to be identified, ensure that all written testimony
includes only your name and does not include personal contact
information. If you wish to remain anonymous, please notify the CFSAC
support team when materials are submitted to cfsac@hhs.gov.

Dated: March 29, 2010.
Wanda K. Jones,
Executive Secretary, CFSAC.
[FR Doc. 2010-7337 Filed 3-31-10; 8:45 am]
BILLING CODE 4150-42-P
 

Hope123

Senior Member
Messages
1,266
Jspotila, I was just going to post this. I'm going to try to change the title of the post to reflect the date.
 

leelaplay

member
Messages
1,576
kelly posted this to CO-CURE today

Federal Register: May 10, 2010 meeting of the HHS CFS Advisory Committee

Note: Last October the HHS had to find a larger room to accommodate all the
researchers, patients, federal employees and advocates who attended the CFS
Advisory Committee meeting.

Possibly as the result of testimony given that day Dr. William Reeves was subsequently
moved out
of the CDC CFS Research Program. Although an agenda has not been made
public, many of the issues raised by attendees remain.

  • The CDC website has a brief statement about the possible pathogen XMRV, but
    the link takes inquirers out of the CFSRP pages.

  • The flawed 2005 empiric definition remains in place.

  • The five-year plan posted on the CDC website continues to contain
    controversial research components.


  • And despite remaining under the
    infectious disease division of the CDC does not have any studies planned
    targeting pathogenicity or biomarkers.

Further information regarding the objections of the largest international
body of CFS biomedical and behavioral educators and researchers can be found
on the IACFS site. www.iacfs.org


[Federal Register: April 1, 2010 (Volume 75, Number 62)]
[Notices]
[Page 16485]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr01ap10-74]
 

leelaplay

member
Messages
1,576
CFSAC Meeting limits time to THREE minutes per speaker

Mary Schweitzer PhD <marymsch@comcast.net> posted this to co-cure today

According to the information in the Federal Register for the CFSAC meeting on 10 May 2010, "Time slots for public comment will be limited to three (3) minutes per speaker; no exceptions will be made."

THREE minutes per speaker, for people with brain damage???

The CFSCC (which existed during the Clinton administration; it was replaced by the CFSAC three years into the Bush administration) had better attendance, allowed five minutes for testimony but ALSO allowed 3-5 questions from the public after each ex officio member's presentation.

It's like pushing a string - they give in on one issue (live streaming) but make the others worse (no questions permitted from the public, and public members now have REDUCED time for their verbal testimony.)

I hope they make up for it by accomplishing something - like really stopping the psychiatric program on CFS at CDC and Emory.

Mary Schweitzer
 

Hope123

Senior Member
Messages
1,266
IF, Mary S.'s issues can be written about to Dr. Jones before the meeting also. She and others can request that more than 3 minutes be allowed for each speaker depending on the number of speakers and that questions be permitted from the public.

Other possibilities: allowing people to give up their spot to another speaker they feel needs to be heard more than them.

My point is: it's fine to vent among ourselves but if we don't tell the people who have control over this what we want, we don't have a chance of getting it.